[ad_1]
Dublin, October 28, 2020 (GLOBE NEWSWIRE) – The ‘Hematology and Coagulation Markets (Laboratory Based and Decentralized Markets)’ report has been added to ResearchAndMarkets.com offer.
Ematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing test markets.
The report contains some discussions on COVID-19 in relation to the hematology and coagulation markets. Several global health organizations and healthcare professionals have reported adverse effects of COVID-19 in patients with blood diseases, including rare diseases such as sickle cell anemia and thalassemia.
Coagulation testing, including d-dimer, is considered a growing indicator of the clinical impact and outcomes of patients with COVID-19. Several international organizations are leading the assignment to identify and publish recommendations and guidelines for the management of coagulopathy in COVID-19 patients.
Hematology is the study of peripheral blood cells and bone marrow in order to diagnose various blood diseases including leukemia, anemia and autoimmune diseases. Hematology menu includes: CBC + 5-part differential (or 3-part differential), manual differential / review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell count (WBC) , platelet count and analysis and red blood cell count (RBC).
Examination of the global market for blood tests includes analyzers / instruments and reagents: all commercial laboratory and hospital products, some research products used in clinical laboratories, and sales of OTC products (not testing services).
Market data points presented include:
- Global Hematology Tests Market by Product Segment, 2019-2024 ($ Million) (Laboratory-Based Hematology, Decentralized [POC] Hematology, Hematology Testing Market)
- Global Laboratory-Based Hematology Instruments and Tests Market, 2019 and 2024 (USD Million)
- Global Laboratory Based Hematology Instruments and Tests Market, by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
- Tier 1 Hematology, Business Revenue (Lab and POC), 2019 ($ Million)
- Decentralized market for hematology tests and instruments, 2019 and 2024 (millions of dollars)
- Global Decentralized Hematology Instruments and Tests Market, by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
- Distribution of hematology analyzer sales by menu functionality, 2019 estimate (%) (sales of 5-part difference analyzers, sales of 3-part difference analyzers, other analyzers)
- Laboratory Hematology Sales for Analyte, 2019 Estimated (%) (CBC, Hemoglobin, Other Specialty)
Hemostasis (coagulation) is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis and platelet aggregation are part of this process. Haemostasis testing needs vary from laboratory to laboratory, with some facilities only performing routine preoperative tests (PT / INR and PTT), while others also conduct special tests (clotting factors).
In both scenarios, the steady increase in patient test volumes, coupled with the growing demand for rapidly producing reliable results, has required laboratories to seek haemostasis testing solutions that improve efficiency by providing consistent results and streamlining flow of work.
The global market assessment for coagulation tests (laboratory based and all POCs) includes d-dimer as a market segment.
Market data points presented:
- Global Coagulation Diagnostics Markets by Segment, 2019-2024 ($ Million) (PT / INR – Lab, D-dimer – Lab, Molecular – Lab, Professional POC, Self POC)
- Distribution of global D-dimer sales by region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
- Global Coagulation Instruments and Tests Market by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
- Main Coagulation Company Revenue (Lab and POC Based), 2019 (USD Million)
Key topics covered:
Chapter 1: Executive Summary
- Overview of Hematology
- Hematology market overview
- Overview of coagulation
- Coagulation Market Overview
- Field of application and methodology
- COVID-19 and Hematology / Coagulation
- Hematology
- Coagulation
Chapter 2: Hematology Overview and Trends
- introduction
- Digital image analysis
- Lab Automation n The digital evolution
- Quality Control Measurement Programs
Chapter 3: Laboratory-Based Hematology Tests
- Overview
- Product Overview
- Market summary
- Regional market for laboratory-based hematology instruments and tests
Chapter 4: Decentralized Hematology Tests
- Overview
- Hemoglobin / Hematocrit at POC
- Market summary
- Decentralized regional market for hematology tests and instruments
Chapter 5: Hematology Market Analysis – Leading Suppliers
- Summary
- The commercial prospects for hematology tests
Chapter 6: Coagulation Market
- Special topics
- COVID-19
- Direct oral anticoagulants (DOACs)
- D-dimer
- Industry acquisitions related to coagulation tests
- Market analysis
- Laboratory based tests
- Genetic markers of hypercoagulopathies
- Decentralized coagulation test n Professional use
- Decentralized coagulation test n OTC
- Platelet test
- Main suppliers
- The commercial market for coagulation tests
Chapter 7: Company Profiles and Review
- Abbott Diagnostics
- Beckman Coulter, Inc./Danaher
- CellaVision AB
- Stago Diagnostics, SAS
- DIAGON Kft. Hungary
- HemoCue / Radiometer / Danaher
- Horiba Medical
- Medica Corporation
- Microvisk Technologies
- Mindray – Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Werfen (Instrumentation Laboratory, Accriva Diagnostics)
- West Medica
For more information on this report, please visit https://www.researchandmarkets.com/r/gvr4ft
Research and Markets also offers personalized research services that provide targeted, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
.
[ad_2]
Source link
